European Psychiatry: Volume 15 -

European Psychiatry

Only show content I have access to (997)

Over 3 years (1069)

View selected items
Save to my bookmarks
Export citations
Download PDF (zip)
Save to Kindle
Save to Dropbox
Save to Google Drive
Save content to
To save this undefined to your undefined account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you used this feature, you will be asked to authorise Cambridge Core to connect with your undefined account. Find out more about saving content to .

To save this article to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Please be advised that item(s) you selected are not available.
You are about to save
European Psychiatry
ISSN: 0924-9338

EISSN: 1778-3585

URL: /core/journals/european-psychiatry
Your Kindle email address

Please provide your Kindle email.

@free.kindle.com @kindle.com (service fees apply)

By using this service, you agree that you will only keep content for personal use, and will not openly distribute them via Dropbox, Google Drive or other file sharing services

European Psychiatry

Refine listing

Actions for selected content:

Volume 15 - October 2000

Posters, Sunday, 29 October 2000

Symposia

P01.83 Degrees of mental disorder in vasqulocerebral pathology

P01.84 Neurofibromatosis type 1: Neuropsychology and MRI correlates

P01.85 Addictions: Situation in belarus by 2000

P01.86 Preliminary results from the international personality disorders examination (IPDE) field trial in Greece

P01.87 Dexamethasone suppression test, personality disorders and stressful life events in clinical subtypes of major depression

P01.88 Attempted suicide by hanging in young children

P01.89 Applying the work of wilfred bion to the treatment of psychotic adolescents

P01.91 Behavioural genetics of cognitive disturbances in schizophrenia

P01.90 Effects of clozapine on autonomic functions: Non-invasive biomonitoring from the skin

P01.92 Multicenter double bind randomized oarralkel-group clinical trial of effectiveness of the combinaion clomipramine plus lithium carbonate versus clomipramine plus placebo in the treatment of unipolar depression

P01.93 The networking model in the prevention of child abuse and neglect

P01.94 First episode of schizophrenia — Efifcacy of olanzapine as first choice neuroleptic

P01.95 Psychosocial correlates of endocrine disease: The integration of different criteria

P01.96 Quality of life profile in patients with suicidal activity (ideation or attempt)

P01.97 Health status and elderly people

P01.99 Suicidal behaviour and the tryptophan hidroxylase and the apolipoprotein E genes polymorphisms

P01.98 Apolipoprotein e genotype and schizophrenia

P01.100 Long-term efficacy of olanzapine in the control of psychotic and behavioral symptoms in patients with alzheimer's dementia

P01.101 Possible mechanisms for the efficacy of olanzapine in preventing relapse in schizophrenia

P01.102 Olanzapine in the prevention of psychosis among nursing home patients with behavioral disturbances associated with Azheimer's disease

European Psychiatry

Refine listing

Actions for selected content:

Save Search

Volume 15 - October 2000

Posters, Sunday, 29 October 2000

Symposia